--- title: "IP Strategy: The Distance Between a Registration Schedule and an Institutional Capability" description: "IP strategy is a written, owned decision framework governing which knowledge a company protects by registration, which by contract, and which not at all. Diligence looks for the reproducibility of the decision that generated the portfolio, not the size of the portfolio. Absent that framework, existing registrations are priced as isolated, founder-dependent outcomes." url: https://www.beirek.com/en/blog/ip-strategy-due-diligence-valuation canonical: https://www.beirek.com/en/blog/ip-strategy-due-diligence-valuation published: 2026-07-01 modified: 2026-07-01 category: "Intellectual Property" category_url: https://www.beirek.com/en/blog/category/intellectual-property language: en-US reading_time_minutes: 7 publisher: BEIREK LLC publisher_url: https://www.beirek.com license: "© BEIREK LLC — citation with attribution and link permitted" keywords: ["IP strategy","intellectual property due diligence","invention disclosure process","representations and warranties","escrow and conditions precedent","founder dependency","investment readiness"] topics: ["Intellectual property governance in investment readiness reviews","How IP gaps translate into deal structure rather than valuation discounts","Designing a reproducible protection decision framework","Measuring IP management through decision flow rather than portfolio stock"] alternate_language_url: https://www.beirek.com/tr/blog/ip-strategy-due-diligence-valuation --- # IP Strategy: The Distance Between a Registration Schedule and an Institutional Capability > **In short:** IP strategy is a written, owned decision framework governing which knowledge a company protects by registration, which by contract, and which not at all. Diligence looks for the reproducibility of the decision that generated the portfolio, not the size of the portfolio. Absent that framework, existing registrations are priced as isolated, founder-dependent outcomes. *A company's intellectual property strategy is assessed in diligence not by the length of its patent and trademark schedule, but by who decides what knowledge gets protected, on what cadence, and against what written record. Where that decision cannot be reproduced independently of the founder, the consequence typically surfaces not as a valuation discount but as deal structure.* --- When the intellectual property section of a diligence session opens, the first document placed on the table is almost invariably the same: a schedule of granted patents, utility models, registered marks, and domain names, generally prepared with care, complete as to filing dates, jurisdictions, annuity status, and the responsible agent of record. The room stays comfortable while the questions remain inside that schedule. It changes character when the reviewer's next question moves to what the schedule excludes — how many technical solutions developed over the preceding three years never entered it, and who determined, on what stated basis, that they should not. In most companies no ready answer exists, because exclusion was never taken as a decision; it occurred passively, in the form of an application that was simply never filed. The same pattern is visible from the opposite direction. In a technology-intensive business, the patent portfolio frequently clusters into two or three consecutive years, and those years usually coincide with an identifiable external trigger — a financing round in preparation, a competitor's publication that landed on the founder's desk, or the arrival of new outside counsel with an agenda. In the years that follow, the product continues to evolve while the portfolio holds flat. The engineering team did not become less inventive during that interval; the external stimulus that had been substituting for a decision mechanism disappeared, and because no mechanism had ever been constructed, nothing operated in its absence. The mechanism underneath both patterns is the internal distribution of information asymmetry. The competence required to judge whether a given solution is worth protecting sits with the development team, while the competence required to judge the form that protection should take — patent, trade secret, contractual restriction, or defensive publication establishing prior art — sits with the legal function. Absent a deliberately constructed interface between the two, the decision falls into the space between them. Engineering treats the question as legal and does not raise it; counsel treats it as technical and, receiving no instruction, does not ask. This is a configuration in which no participant makes an error, and precisely for that reason it does not correct itself. A second mechanism operates through the timing of cost recognition. The expense of a patent application is incurred immediately and, once national phase entries and jurisdictional extensions are counted, commits cash across a five-year horizon, whereas the economic value of the protection obtained becomes visible only at the moment of an infringement, a licensing negotiation, or an exit transaction. For a company operating under cash discipline, the asymmetry between a certain present expenditure and a contingent future benefit pushes the protection decision toward deferral in an entirely predictable way. Deferral is defensible taken once; the difficulty is that it ceases to be a decision at all and becomes a default renewed silently each year. Translated into the language of the party conducting the review, the institutional cost of these two mechanisms takes a single form: the legal status of the company's most valuable technical knowledge is indeterminate. That indeterminacy cuts in two directions. On one side, the possibility that unprotected knowledge has already migrated outward — through a departing employee, a supplier relationship, or a customer integration performed under a loosely drafted statement of work — cannot be priced. On the other, where no freedom-to-operate assessment has been performed against third-party rights, that exposure sits entirely off the balance sheet. A reviewer confronted with a risk that resists pricing responds not with a discount but with structure. The channels through which that structure is applied are well established, and the sell side commonly encounters them only after the valuation discussion has closed, in the course of contract negotiation. Intellectual property representations are carved out of the general indemnity cap and attached to a separate, materially longer survival period; the escrow is sized not solely against transaction value but with an incremental tranche calculated specifically against the IP heading; the retroactive completion of employee invention assignment documentation is written in as a condition precedent to closing. None of these reduces the headline price, yet each renders a portion of the seller's proceeds contingent for years. The aggregate economic effect can comfortably exceed the difference of several turns of multiple. Founder dependency assumes a particularly quiet form under this heading. The person who knows which knowledge is genuinely load-bearing, which solution a competitor could replicate within a quarter, and which component would remain commercially inert even if copied is, in most companies, the founder or the founding technical partner. That knowledge exists nowhere in writing, because nobody ever asked for it in writing. While that person remains in the room, protection decisions look reasonable from the outside and an observer may reasonably mistake the pattern for a working strategy. Once the post-closing retention period expires, what remains is a portfolio schedule and a team that does not know the logic by which it was assembled — and the continuity dimension of the review is looking for exactly that gap. Measurement is the dimension most frequently left empty here, largely because the metric the market has settled on — the count of registered rights — conveys almost nothing about management quality. Meaningful measurement looks past the stock of the portfolio to the flow of the decision: the median interval between the filing of an invention disclosure and a recorded protection decision, the proportion of key technical personnel covered by executed confidentiality and invention assignment agreements, the date on which open-source components were last screened for license compliance, and the share of registered rights that map to a product actually being sold. These four indicators describe whether an IP strategy is functioning far more accurately than the portfolio schedule does, and none of them is expensive to collect. The intervention BEIREK applies in this area begins by moving the protection decision out of intuition and onto a record. In practice it comprises three components: an intake gate through which every technical output enters the record by way of a single-page disclosure form; a fixed-cadence review in which the technical and legal sides sit together and convert those forms into decisions; and — the component that carries the most weight in diligence — a written rationale for the decision not to protect. The third is omitted in most companies, yet it is the differentiating item at the review table, since a recorded rationale for non-protection demonstrates both that a decision was taken and that it rested on reasoning. Two further layers sit on top of that framework. The first is ownership: assignment of the IP heading to a single named individual, typically a senior manager on the product or technology side, vested with a defined budget and decision authority and carrying a periodic reporting obligation to the board. The second is the evidentiary chain: a retrospective sweep of invention assignment provisions in employment agreements, work-product ownership clauses in contractor and consultant engagements, and the allocation of rights in customer-specific development, followed by remediation of whatever gaps that sweep exposes. Performed before a transaction is contemplated, this is routine document work; imposed as a condition precedent, it is performed under calendar pressure with a counterparty watching, and its cost profile is entirely different. What sustains the implementation dimension over time is not the sophistication of the process design but the sparseness of its cadence. A quarterly review with an agenda that never exceeds a single page generates institutional memory on a scale that a committee scheduled monthly and abandoned in its second month cannot approach. The same logic governs measurement: a four-indicator table is more valuable than a fifteen-indicator dashboard, for the straightforward reason that it is far more likely to still be maintained two years later. The evidence of institutional capability lies in the uninterrupted continuity of the record rather than in the elegance of its architecture. A company's intellectual property strategy is ultimately valued not by the rights it holds but by the traceability of the decisions it made about holding them. The reviewer can already see the portfolio; what remains invisible, and therefore unpriceable, is whether that portfolio will continue to grow tomorrow according to the same logic. The question worth putting internally is not how many patents the company owns, but whether the reasoning behind the most recent decision not to protect something could be produced in writing today, to a stranger, without preparation. ## Key Points - A registration portfolio is the output of a strategy, and its existence does not by itself demonstrate that a functioning decision mechanism produced it. - In most companies the protection decision is taken by the engineering team's intuition rather than by a defined process, which leaves no record and therefore nothing a reviewer can verify. - The absence of an IP strategy tends to reach valuation through representation and warranty scope, escrow sizing, and conditions precedent rather than through a reduction in the headline multiple. - Where ownership of the topic is diffuse, counsel constrains on cost, the technical team defers, and the decision is never taken at all; this gap is the most durable form of founder dependency. - Meaningful measurement tracks the interval from invention disclosure to a recorded decision and the contractual coverage ratio of key personnel, not the count of granted rights. ## Questions ### Which documents are requested for IP strategy during due diligence? Beyond the registration schedule, four document groups are typically requested: invention disclosure and assessment files in which protection decisions and their rationales are recorded, invention assignment provisions in employee and consultant agreements, open-source license compliance screening results, and the contractual clauses allocating ownership in customer-specific development work. Gaps in these groups generally return to the table later as conditions precedent to closing. ### Does the number of patents directly increase company valuation? A direct relationship is rarely established. What proves decisive in review is whether registered rights map to the product actually being sold, and whether the mechanism generating protection decisions operates independently of the founder. A broad portfolio unaligned with the product line may be read as a maintenance-fee expense item, while a narrow portfolio aligned with the revenue-generating product provides genuine negotiating leverage. ### How formal should a smaller company's IP strategy be? Formality is calibrated to traceability rather than headcount. In a thirty-person company, a single-page invention disclosure form, a short quarterly review, and a record in which decisions not to protect are also written down will generally suffice. What matters is not documentary volume but the uninterrupted continuity of the record and the assignment of the heading to one accountable individual with real decision authority. ### How does an IP gap actually reach valuation? It usually arrives as transaction structure rather than as a multiple reduction. Intellectual property representations are carved out of the general indemnity cap and given a longer survival period, escrow is incrementally sized against this heading specifically, and completion of missing invention assignment documentation becomes a condition precedent. The headline price holds, while a portion of the seller's proceeds remains contingent for several years. --- Source: https://www.beirek.com/en/blog/ip-strategy-due-diligence-valuation Publisher: BEIREK LLC — https://www.beirek.com